查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
活細胞封裝市場 - 2018-2028 年全球行業規模、佔有率、趨勢、競爭、機會及預測，按聚合物類型、應用、技術和地區分類
市場調查報告書
商品編碼
1309226

活細胞封裝市場 - 2018-2028 年全球行業規模、佔有率、趨勢、競爭、機會及預測，按聚合物類型、應用、技術和地區分類

Live Cell Encapsulation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Polymer Type, By Application, By Technique, By Region
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2024-2028 年的預測期內，活細胞封裝市場預計將以驚人的複合年成長率成長。這可歸因於在提高細胞封裝技術有效性方面的研發不斷成長，以及支持活細胞封裝產品開發的政府和私人投資增加等因素。

細胞療法的增加

活細胞封裝技術能以可控方式輸送藥用細胞成分或生物活性材料，因此能有效地用於細胞療法，因為它們能將治療藥物直接輸送到體內的目標位置。此外，它們不會引起人體免疫系統的任何反應，因此不會被免疫系統攻擊或清除。在某些情況下，封裝細胞還能執行特定功能，如激活抗癌藥物。例如，2021 年，一家名為Nuvilex 的公司進行了一項研究，將活細胞封裝在珠子中，用於治療胰腺癌。據觀察，細胞將非活性抗癌藥物伊佛醯胺轉化為殺癌形式，這一特殊性質確保了化療藥物直接輸送到腫瘤，因此被認為在未來具有潛在用途。

慢性疾病發病率上升

癌症、糖尿病等慢性疾病的發病率在全球範圍內不斷上升，成為全球關注的主要健康問題。根據國際糖尿病基金會的報告，2021 年約有5.37 億成年人患有糖尿病，預計到2030 年將增至6.43 億，到2045 年將達到7.83 億。活細胞包裹技術在治療慢性疾病（如1 型糖尿病、癌症和自身免疫性疾病）方面的應用的推出和認知度的提高，預計將推動市場的發展。例如，活細胞包裹技術可用於向1 型糖尿病患者輸送胰島素分泌細胞，向帕金森氏症患者輸送多巴胺。因此，慢性疾病數量的不斷成長為公司涵蓋和加強活細胞封裝技術創造了巨大需求，從而有望在預測期內促進市場成長。

不斷加強研發以提高產品功效

隨著生物技術的不斷發展，公司對活細胞封裝技術的研發和投資不斷增加，從而提高了活細胞封裝技術的開發和臨床療效。主要市場參與者為提高活細胞封裝技術的應用和生產而不斷增加的投資和相互聯繫進一步促進了全球活細胞封裝市場的成長。例如，2022 年11 月，領先的生物相容性材料供應商BIO INX 與微細加工技術領先企業Nanoscribe 合作，推出了HYDROBIO INX N400，該產品可實現高解析度的細胞封裝，即3D 列印，特別適用於3D 微細加工。此外，2021 年7 月，一家臨床生物技術公司- PharmaCyte Biotech，利用活細胞封裝技術開發出了癌症和糖尿病的靶向治療方法，並開始了用於研究活細胞封裝技術治療糖尿病的兩階段豬研究的第一階段。因此，不斷發展的研究為公司提供了提高活細胞封裝技術的機會。

可客製化

TechSci Research 可根據給定的市場數據，按照公司的具體需求提供客製化服務。報告可提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：產品概述

  • 市場定義
  • 市場範圍
    • 市場覆蓋範圍
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目標
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4章：客戶之聲

第5章：活細胞封裝市場前景。

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按聚合物類型（海藻酸鹽、殼聚醣、硫酸纖維素及其他）
    • 按應用（給藥、再生醫學、細胞移植和益生菌）
    • 按技術（簡單滴注、靜電滴注和同軸氣流
    • 按公司（2022 年）
    • 按地區
  • 產品市場地圖

第6 章: 亞太地區活細胞封裝市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 聚合物類型
    • 應用
    • 技術
    • 按國家
  • 亞太地區：國家分析
    • 中國.
    • 印度.
    • 印度.
    • 日本
    • 澳大利亞

第7 章: 歐洲活細胞封裝市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 聚合物類型
    • 應用
    • 技術
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8 章: 北美活細胞封裝市場前景。

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 聚合物類型
    • 應用
    • 技術
    • 按國家
  • 北美洲：國家分析
    • 美國活細胞封裝市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 聚合物類型
        • 應用
        • 技術
    • 墨西哥活細胞封裝市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 聚合物類型
        • 應用
        • 技術
    • 加拿大活細胞封裝市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 聚合物類型
        • 應用
        • 技術

第9章：南美洲活細胞封裝市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 聚合物類型
    • 應用
    • 技術
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10 章: 中東和非洲活細胞封裝市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 聚合物類型
    • 應用
    • 技術
    • 按國家
  • 中東和非洲：國家分析
    • 南非活細胞封裝
    • 沙烏地阿拉伯活細胞封裝
    • 阿拉伯聯合大公國活細胞封裝
    • 科威特活細胞封裝

第11 章：市場動態

  • 驅動因素
  • 挑戰

第12 章：市場趨勢與發展

  • 近期動態
  • 合併與收購
  • 產品開發

第13 章：競爭格局

  • 業務概述
  • 公司概況
  • 產品與服務
  • 財務狀況（上市公司）
  • 近期發展
  • SWOT 分析
    • AUSTRIANOVA
    • Merck KGaA
    • Sphere Fluidics Ltd.
    • ViaCyte, Inc.
    • Blacktrace Holdings Ltd. (Dolomite Microfluidics)
    • BIO INX
    • Living Cell Technologies Ltd.
    • Sigilon Therapeutics, Inc.
    • Isogen
    • Diatranz Otsuka Ltd.

第14 章：戰略建議

簡介目錄
Product Code: 15047

Live Cell Encapsulation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research & development in improving the effectiveness of cell encapsulation technologies, along with the rise in governmental and private investments supporting live cell encapsulated product development.

Live cell encapsulation is a bioengineering technology that includes encasing living cells with a material or coating. A distinct variety of materials are used for encapsulation, such as liposomes, hydrogels, and microcapsules.

Moreover, live-cell encapsulation is found to have significant importance in cell therapies as it allows a controlled release of bioactive material or cells and thereby is anticipated to bolster the market growth with the rise in cell therapies across the globe.

Increase in Cell Therapies

The live cell encapsulation delivers the medicinal cell component or bioactive materials in a controlled manner and thus is efficient to be used in cell therapies as they include the delivery of therapeutics directly in the targeted location in the body. Additionally, they do not create any response by the body's immune system and thus aren't attacked or eliminated by the immune system. The encapsulated cells, in some cases, carry out specific functions, such as activating cancer drugs. For instance, in 2021, a company called Nuvilex performed a research study in which the live cells were encapsulated within beads to treat pancreatic cancer. It was observed the cells converted the inactive cancer drug ifosfamide into its cancer-killing form, and this specific property ensures the delivery of the chemotherapeutic drug directly to the tumor and thereby is found to have potential usage in the future.

Rising Prevalence of Chronic Diseases

Chronic diseases such as cancer, diabetes, etc., are rising across the globe and are a major health concern worldwide. According to the report by the International Diabetes Foundation, in 2021, around 537 million adults were affected by diabetes, and it is expected to increase to 643 million by 2030, and by 2045, it will reach 783 million. The introduction and increased awareness about the applications of live cell encapsulation in the treatment of chronic diseases such as type 1 diabetes, cancer, and autoimmune diseases are expected to boost the market. For instance, the live cell encapsulation technology is used for delivering insulin-producing cells to the patient suffering from type 1 diabetes and dopamine delivering in the case of Parkinson's disease. Thus, the growing number of chronic diseases is creating a huge demand for companies to include and enhance live cell encapsulation and thereby is expected to bolster the market growth in the forecast period.

Growing Research & Development to Improve Product Efficacy

The growing expansion of biotechnology with increasing research & development and rising company investments in live cell encapsulation technologies is leading to improvement in the development and clinical efficacy of live cell encapsulation. The growing investment and increased mutual associations to enhance the live cell encapsulation technological application and production by the key market players are further contributing to the growth of the global live cell encapsulation market. For instance, In November 2022, a leading supplier of biocompatible materials- BIO INX, collaborated with Nanoscribe- a microfabrication technology leader and introduced HYDROBIO INX N400- that enables cell encapsulation in high resolution, i.e., 3D printing and is especially designed for 3D microfabrication. Additionally, in July 2021, a clinical biotechnology company -PharmaCyte Biotech, developed targeted treatments for cancer and diabetes using the live-cell encapsulation technique and commenced the first phase of a two-phase pig study used for investigating live-cell encapsulation technology for diabetes treatment. Thus, growing research is providing opportunities for companies to enhance the live cell encapsulation technique.

Market Segmentation

Global Live Cell Encapsulation Market is segmented based on polymer type, application, technique, region, and competitive landscape. Based on polymer type, the market is segmented into alginate, chitosan, cellulose sulfate, and others. Based on application, the market is segmented into drug delivery, regenerative medicine, cell transplantation, and probiotics. Based on technique, the market is segmented into simple dripping, electrostatic dripping, and coaxial airflow. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), BIO INX, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc., Isogen, Diatranz Otsuka Ltd. are some of the major players operating in the Global Live Cell Encapsulation Market.

Report Scope

In this report, Global Live Cell Encapsulation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Live Cell Encapsulation Market, By Polymer Type:

  • Alginate
  • Chitosan
  • Cellulose Sulfate
  • Others

Live Cell Encapsulation Market, By Application:

  • Drug Delivery
  • Regenerative Medicine
  • Cell Transplantation
  • Probiotics

Live Cell Encapsulation Market, By Technique:

  • Simple Dripping
  • Electrostatic Dripping
  • Coaxial Airflow

Live Cell Encapsulation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Live Cell Encapsulation Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Live Cell encapsulation Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Polymer Type (Alginate, Chitosan, Cellulose Sulfate and Others)
    • 5.2.2. By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics)
    • 5.2.3. By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow
    • 5.2.4. By Company (2022)
    • 5.2.5. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Live Cell encapsulation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Polymer Type
    • 6.2.2. Application
    • 6.2.3. Technique
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Live Cell encapsulation Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Polymer Type
        • 6.3.1.2.2. Application
        • 6.3.1.2.3. Technique
    • 6.3.2. India Live Cell encapsulation Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Polymer Type
        • 6.3.2.2.2. Application
        • 6.3.2.2.3. Technique
    • 6.3.3. South Korea Live Cell encapsulation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Polymer Type
        • 6.3.3.2.2. Application
        • 6.3.3.2.3. Technique
    • 6.3.4. Japan Live Cell encapsulation Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Polymer Type
        • 6.3.4.2.2. Application
        • 6.3.4.2.3. Technique
    • 6.3.5. Australia Live Cell encapsulation Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Polymer Type
        • 6.3.5.2.2. Application
        • 6.3.5.2.3. Technique

7. Europe Live Cell encapsulation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Polymer Type
    • 7.2.2. Application
    • 7.2.3. Technique
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Live Cell encapsulation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Polymer Type
        • 7.3.1.2.2. Application
        • 7.3.1.2.3. Technique
    • 7.3.2. Germany Live Cell encapsulation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Polymer Type
        • 7.3.2.2.2. Application
        • 7.3.2.2.3. Technique
    • 7.3.3. United Kingdom Live Cell encapsulation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Polymer Type
        • 7.3.3.2.2. Application
        • 7.3.3.2.3. Technique
    • 7.3.4. Italy Live Cell encapsulation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Polymer Type
        • 7.3.4.2.2. Application
        • 7.3.4.2.3. Technique
    • 7.3.5. Spain Live Cell encapsulation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Polymer Type
        • 7.3.5.2.2. Application
        • 7.3.5.2.3. Technique

8. North America Live Cell encapsulation Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Polymer Type
    • 8.2.2. Application
    • 8.2.3. Technique
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Live Cell encapsulation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Polymer Type
        • 8.3.1.2.2. Application
        • 8.3.1.2.3. Technique
    • 8.3.2. Mexico Live Cell encapsulation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Polymer Type
        • 8.3.2.2.2. Application
        • 8.3.2.2.3. Technique
    • 8.3.3. Canada Live Cell encapsulation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Polymer Type
        • 8.3.3.2.2. Application
        • 8.3.3.2.3. Technique

9. South America Live Cell encapsulation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Polymer Type
    • 9.2.2. Application
    • 9.2.3. Technique
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Live Cell encapsulation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Polymer Type
        • 9.3.1.2.2. Application
        • 9.3.1.2.3. Technique
    • 9.3.2. Argentina Live Cell encapsulation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Polymer Type
        • 9.3.2.2.2. Application
        • 9.3.2.2.3. Technique
    • 9.3.3. Colombia Live Cell encapsulation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Polymer Type
        • 9.3.3.2.2. Application
        • 9.3.3.2.3. Technique

10. Middle East and Africa Live Cell encapsulation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Polymer Type
    • 10.2.2. Application
    • 10.2.3. Technique
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Live Cell encapsulation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Polymer Type
        • 10.3.1.2.2. Application
        • 10.3.1.2.3. Technique
    • 10.3.2. Saudi Arabia Live Cell encapsulation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Polymer Type
        • 10.3.2.2.2. Application
        • 10.3.2.2.3. Technique
    • 10.3.3. UAE Live Cell encapsulation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Polymer Type
        • 10.3.3.2.2. Application
        • 10.3.3.2.3. Technique
    • 10.3.4. Kuwait Live Cell encapsulation Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Polymer Type
        • 10.3.4.2.2. Application
        • 10.3.4.2.3. Technique

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. AUSTRIANOVA
    • 13.6.2. Merck KGaA
    • 13.6.3. Sphere Fluidics Ltd.
    • 13.6.4. ViaCyte, Inc.
    • 13.6.5. Blacktrace Holdings Ltd. (Dolomite Microfluidics)
    • 13.6.6. BIO INX
    • 13.6.7. Living Cell Technologies Ltd.
    • 13.6.8. Sigilon Therapeutics, Inc.
    • 13.6.9. Isogen
    • 13.6.10. Diatranz Otsuka Ltd.

14. Strategic Recommendations